Eradicating hepatitis C
Are novel screening strategies for people who inject drugs cost-effective
Bibliographic Data
| ID | 14906215 |
|---|---|
| Authors | Francesco Manca (0000-0003-2823-9892, University of Glasgow, corresponding author), Emma Robinson (0000-0002-2357-7262, Ninewells Hospital), Jessica Dillon (0000-0002-2164-4476, Ninewells Hospital), John F Dillon, Kathleen Anne Boyd, Kathleen Boyd (0000-0002-9764-0113, University of Glasgow) |
| Year | 2020 |
| Volume | 82 |
| Pages | 102811 |
| Publication date | 2020-08-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | International Journal of Drug Policy (JOURNAL) |
| Journal identifiers | ISSN: 0955-3959 • E-ISSN: 1873-4758 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.drugpo.2020.102811 |
| PMID | 32585583 |
| OpenAlex | W3036009005 |
| Language | EN |
| Citations received | 3 |
| References cited | 26 |
Targeting PWID populations with screening at needle exchange services is a highly cost-effective strategy for reaching undiagnosed HCV patients. When applying realistic discounts to list prices of drug treatments, all three strategies were highly cost-effective from a UK NHS perspective. All of these strategies have the potential to make a cost-effective contribution to the eradication of HCV by 2030
Cost effectiveness · Cost–benefit analysis · Family medicine · Hepatitis C · Risk analysis (engineering · Hepatitis C virus research · HIV, Drug Use, Sexual Risk · Liver Disease Diagnosis and Treatment · Medicine · Pharmacy · Virology
| Unique citing works | 3 |
|---|---|
| Citations per year | 0.5 |
| Citation span | 2020 - 2024 (5) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 3 |